Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for biopharmaceutical products
3.2.1.2 Advancements in biotechnology and bioprocessing
3.2.1.3 Increasing demand for biosimilars
3.2.1.4 Rising government initiatives and funding
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of instruments
3.2.2.2 Complexity and technical expertise
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.4.3 Asia Pacific
3.5 Technological landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
4.6 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Consumables & accessories
Chapter 6 Market Estimates and Forecast, By Analysis Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Substrate analysis
6.3 Metabolite analysis
6.4 Concentration detection
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Antibiotics
7.3 Recombinant proteins
7.4 Biosimilars
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Biopharmaceutical companies
8.3 CROs & CMOs
8.4 Research & academic institutes
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 4BioCell GmbH & Co. KG-
10.2 Agilent Technologies, Inc.
10.3 Danaher Corporation
10.4 Endress+Hauser Group Services AG
10.5 Eppendorf AG
10.6 F. Hoffmann-La Roche Ltd.
10.7 Nova Biomedical
10.8 Randox Laboratories Ltd.
10.9 Sartorius AG
10.10 Solida Biotech GmBH
10.11 SYSBIOTECH GmbH
10.12 Thermo Fisher Scientific Inc.
10.13 Xylem Inc.
